H

HaTay Pharmaceutical JSC
VN:DHT

Watchlist Manager
HaTay Pharmaceutical JSC
VN:DHT
Watchlist
Price: 71 900 VND 4.2% Market Closed
Market Cap: 6.5T VND

Operating Margin
HaTay Pharmaceutical JSC

3.3%
Current
5%
Average
5.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
3.3%
=
Operating Profit
71.5B
/
Revenue
2.2T

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
VN
HaTay Pharmaceutical JSC
VN:DHT
6.5T VND
3%
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
27%
CH
Roche Holding AG
SIX:ROG
277.8B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP
24%
CH
Novartis AG
SIX:NOVN
221.8B CHF
33%
US
Merck & Co Inc
NYSE:MRK
270.7B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
42%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
11%
US
Pfizer Inc
NYSE:PFE
145.8B USD
29%
No Stocks Found

HaTay Pharmaceutical JSC
Glance View

Market Cap
6.5T VND
Industry
Pharmaceuticals

Ha Tay Pharmaceutical JSC engages in the manufacture, import and export of drugs, medicine, cosmetic and medical equipment. The company is headquartered in Hanoi, Hanoi. The company went IPO on 2008-12-03. The company is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The firm also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The firm announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.

DHT Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
3.3%
=
Operating Profit
71.5B
/
Revenue
2.2T
What is the Operating Margin of HaTay Pharmaceutical JSC?

Based on HaTay Pharmaceutical JSC's most recent financial statements, the company has Operating Margin of 3.3%.

Back to Top